Invesco Ltd. Buys 61,678 Shares of Azenta, Inc. (NASDAQ:AZTA)

Invesco Ltd. boosted its holdings in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 39.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 218,795 shares of the company's stock after buying an additional 61,678 shares during the period. Invesco Ltd. owned about 0.48% of Azenta worth $10,940,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Picton Mahoney Asset Management lifted its holdings in Azenta by 305.7% during the 4th quarter. Picton Mahoney Asset Management now owns 706 shares of the company's stock valued at $35,000 after purchasing an additional 532 shares during the last quarter. Headlands Technologies LLC acquired a new position in Azenta in the fourth quarter valued at approximately $40,000. KBC Group NV grew its holdings in Azenta by 48.5% during the 4th quarter. KBC Group NV now owns 2,137 shares of the company's stock worth $107,000 after acquiring an additional 698 shares during the period. Assenagon Asset Management S.A. bought a new stake in shares of Azenta during the 4th quarter valued at $200,000. Finally, Landscape Capital Management L.L.C. bought a new position in shares of Azenta in the 4th quarter worth $217,000. Institutional investors own 99.08% of the company's stock.

Azenta Price Performance

Shares of AZTA traded down $0.40 during midday trading on Friday, hitting $26.73. The stock had a trading volume of 603,236 shares, compared to its average volume of 646,541. The firm has a market cap of $1.22 billion, a price-to-earnings ratio of -8.97 and a beta of 1.66. The company has a 50 day simple moving average of $35.03 and a two-hundred day simple moving average of $43.26. Azenta, Inc. has a twelve month low of $24.06 and a twelve month high of $63.58.

Azenta (NASDAQ:AZTA - Get Free Report) last released its earnings results on Wednesday, February 5th. The company reported $0.08 EPS for the quarter, beating the consensus estimate of $0.05 by $0.03. Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. Analysts forecast that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts have issued reports on the company. Stephens restated an "overweight" rating and set a $60.00 target price on shares of Azenta in a report on Thursday, January 2nd. Evercore ISI upped their price objective on shares of Azenta from $50.00 to $52.00 and gave the company an "in-line" rating in a research report on Thursday, February 6th. Needham & Company LLC boosted their target price on Azenta from $55.00 to $59.00 and gave the company a "buy" rating in a research note on Thursday, February 6th. Finally, TD Cowen upgraded Azenta to a "hold" rating in a report on Thursday, February 27th.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.